Terms: = Lymphoma AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
154 results:
1. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells.
Liu Y; Zhang S; Tan Y
Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223
[No Abstract] [Full Text] [Related]
2. Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
Tan Q; Gao R; Zhang X; Yang J; Xing P; Yang S; Wang D; Wang G; Wang S; Yao J; Zhang Z; Tang L; Yu X; Han X; Shi Y
Cancer Immunol Immunother; 2024 Feb; 73(3):47. PubMed ID: 38349411
[TBL] [Abstract] [Full Text] [Related]
3. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
4. Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.
Feng Q; Hu K; Hu H; Lu Y; Zhang H; Wang G; Zhang Q; Xu Z; Gao X; Jia X; Zhu H; Song D; Yi H; Peng Y; Wu X; Li B; Zhu W; Shi J
Int Immunopharmacol; 2023 Dec; 125(Pt A):111139. PubMed ID: 37913572
[TBL] [Abstract] [Full Text] [Related]
5. Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.
Forberg AL; Unrau J; Weber KS; Rutz AC; Lund S; Guidinger J; Pelzel A; Hauge J; Hemmen AJ; Hartert KT
Ann Hematol; 2024 Jan; 103(1):199-209. PubMed ID: 37792064
[TBL] [Abstract] [Full Text] [Related]
6. Incidence and Features of Lymphoid Proliferation and lymphomas after Solid Organ or Hematopoietic Stem Cell Transplantation in a National Database Cohort.
Hahn SM; Lee M; Hyun J; Lim S; Kang JM; Ahn JG; Joo DJ; Jung I; Ihn K
Cancer Res Treat; 2024 Jan; 56(1):305-313. PubMed ID: 37475137
[TBL] [Abstract] [Full Text] [Related]
7. An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia.
Patel J; Gao X; Wang H
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108359
[TBL] [Abstract] [Full Text] [Related]
8. A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia.
Wilde L; Porazzi P; Trotta R; De Dominici M; Palmisiano N; Keiffer G; Rancani K; Yingling K; Calabretta B; Kasner M
Leuk Res; 2023 Jun; 129():107075. PubMed ID: 37079999
[TBL] [Abstract] [Full Text] [Related]
9. Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells.
Xie X; Zhang W; Zhou X; Ye Z; Wang H; Qiu Y; Pan Y; Hu Y; Li L; Chen Z; Yang W; Lu Y; Zou S; Li Y; Bai X
Br J Haematol; 2023 Jun; 201(5):940-953. PubMed ID: 36916190
[TBL] [Abstract] [Full Text] [Related]
10. [In vitro pharmacodynamic studies of novel class Ⅰ and Ⅱb selective histone deacetylase inhibitor purinostat mesylate in the treatment of diffuse large B-cell lymphoma and its mechanism].
Wang J; Zhao AL; Li H; Yang LY; Chen LJ; Niu T
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):753-759. PubMed ID: 36709169
[No Abstract] [Full Text] [Related]
11. Induction of Apoptosis via Inactivating PI3K/AKT Pathway in Colorectal Cancer Cells Using Aged Chinese Hakka Stir-Fried Green Tea Extract.
Zhang X; Huang H; Sun S; Li D; Sun L; Li Q; Chen R; Lai X; Zhang Z; Zheng X; Wong WL; Wen S
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500365
[TBL] [Abstract] [Full Text] [Related]
12. [Cell Cycle Arrest and Apoptosis Induced by Atovaquone in Non-Hodgkin's lymphoma Raji Cells].
Chen CY; Shen X; Xing S; Zhang XW; Jiang G; Yu ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1746-1751. PubMed ID: 36476898
[TBL] [Abstract] [Full Text] [Related]
13. Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression.
Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
[TBL] [Abstract] [Full Text] [Related]
14. Galbanic Acid Improves Accumulation and Toxicity of Arsenic Trioxide in MT-2 Cells.
Mahdifar M; Rassouli FB; Iranshahi M; Goudarzi S; Golizadeh M; Rafatpanah H
Anticancer Agents Med Chem; 2023; 23(6):699-708. PubMed ID: 35899960
[TBL] [Abstract] [Full Text] [Related]
15. Cytokinetic-driven myeloprotection after cytotoxic chemotherapy: from an old idea to a new clinical approach.
Sbrana A; Antonuzzo A; Danova M
Support Care Cancer; 2022 Sep; 30(9):7057-7060. PubMed ID: 35484313
[TBL] [Abstract] [Full Text] [Related]
16. Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.
Santoro A; Su WC; Navarro A; Simonelli M; Ch Yang J; Ardizzoni A; Barlesi F; Hyoung Kang J; DiDominick S; Abdelhady A; Chen X; Stammberger U; Felip E
Lung Cancer; 2022 Apr; 166():170-177. PubMed ID: 35298959
[TBL] [Abstract] [Full Text] [Related]
17. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma.
Brivio E; Baruchel A; Beishuizen A; Bourquin JP; Brown PA; Cooper T; Gore L; Kolb EA; Locatelli F; Maude SL; Mussai FJ; Vormoor-Bürger B; Vormoor J; von Stackelberg A; Zwaan CM
Eur J Cancer; 2022 Mar; 164():1-17. PubMed ID: 35121370
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods.
Kotrová M; Koopmann J; Trautmann H; Alakel N; Beck J; Nachtkamp K; Steffen B; Raffel S; Viardot A; Wethmar K; Darzentas N; Baldus CD; Gökbuget N; Brüggemann M
Blood Adv; 2022 May; 6(10):3006-3010. PubMed ID: 35026836
[TBL] [Abstract] [Full Text] [Related]
19. Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and cdk4/6 kinase blockade.
Woess K; Macho-Maschler S; Van Ingen Schenau DS; Butler M; Lassnig C; Valcanover D; Poelzl A; Meissl K; Maurer B; Brandstoetter T; Vogl C; Koren A; Kubicek S; Orlova A; Moriggl R; Strobl B; Sexl V; Van Leeuwen FN; Kuiper RP; Mueller M
Haematologica; 2023 Apr; 108(4):993-1005. PubMed ID: 35021603
[TBL] [Abstract] [Full Text] [Related]
20. The cdk4/6-UCHL5-BRD4 axis confers resistance to BET inhibitors in MLL-rearranged leukemia cells by suppressing BRD4 protein degradation.
Amari K; Sasagawa S; Imayoshi N; Toda Y; Hosogi S; Imamura T; Ashihara E
Biochem Biophys Res Commun; 2022 Jan; 588():147-153. PubMed ID: 34954522
[TBL] [Abstract] [Full Text] [Related]
[Next]